Identification O
of O
APC2 O
, O
a O
homologue O
of O
the O
adenomatous B-Disease
polyposis I-Disease
coli I-Disease
tumour I-Disease
suppressor O
. O

The O
adenomatous B-Disease
polyposis I-Disease
coli I-Disease
( I-Disease
APC I-Disease
) I-Disease
tumour I-Disease
- O
suppressor O
protein O
controls O
the O
Wnt O
signalling O
pathway O
by O
forming O
a O
complex O
with O
glycogen O
synthase O
kinase O
3beta O
( O
GSK O
- O
3beta O
) O
, O
axin O
/ O
conductin O
and O
betacatenin O
. O

Complex O
formation O
induces O
the O
rapid O
degradation O
of O
betacatenin O
. O

In O
colon B-Disease
carcinoma I-Disease
cells O
, O
loss O
of O
APC O
leads O
to O
the O
accumulation O
of O
betacatenin O
in O
the O
nucleus O
, O
where O
it O
binds O
to O
and O
activates O
the O
Tcf O
- O
4 O
transcription O
factor O
( O
reviewed O
in O
[ O
1 O
] O
[ O
2 O
] O
) O
. O

Here O
, O
we O
report O
the O
identification O
and O
genomic O
structure O
of O
APC O
homologues O
. O

Mammalian O
APC2 O
, O
which O
closely O
resembles O
APC O
in O
overall O
domain O
structure O
, O
was O
functionally O
analyzed O
and O
shown O
to O
contain O
two O
SAMP O
domains O
, O
both O
of O
which O
are O
required O
for O
binding O
to O
conductin O
. O

Like O
APC O
, O
APC2 O
regulates O
the O
formation O
of O
active O
betacatenin O
- O
Tcf O
complexes O
, O
as O
demonstrated O
using O
transient O
transcriptional O
activation O
assays O
in O
APC O
- O
/ O
- O
colon B-Disease
carcinoma I-Disease
cells O
. O

Human O
APC2 O
maps O
to O
chromosome O
19p13 O
. O

3 O
. O

APC O
and O
APC2 O
may O
therefore O
have O
comparable O
functions O
in O
development O
and O
cancer B-Disease
. O

A O
common O
MSH2 O
mutation O
in O
English O
and O
North O
American O
HNPCC B-Disease
families O
: O
origin O
, O
phenotypic O
expression O
, O
and O
sex O
specific O
differences O
in O
colorectal B-Disease
cancer I-Disease
. O

The O
frequency O
, O
origin O
, O
and O
phenotypic O
expression O
of O
a O
germline O
MSH2 O
gene O
mutation O
previously O
identified O
in O
seven O
kindreds O
with O
hereditary B-Disease
non I-Disease
- I-Disease
polyposis I-Disease
cancer I-Disease
syndrome I-Disease
( O
HNPCC B-Disease
) O
was O
investigated O
. O

The O
mutation O
( O
A O
- O
- O
> O
T O
at O
nt943 O
+ O
3 O
) O
disrupts O
the O
3 O
splice O
site O
of O
exon O
5 O
leading O
to O
the O
deletion O
of O
this O
exon O
from O
MSH2 O
mRNA O
and O
represents O
the O
only O
frequent O
MSH2 O
mutation O
so O
far O
reported O
. O

Although O
this O
mutation O
was O
initially O
detected O
in O
four O
of O
33 O
colorectal B-Disease
cancer I-Disease
families O
analysed O
from O
eastern O
England O
, O
more O
extensive O
analysis O
has O
reduced O
the O
frequency O
to O
four O
of O
52 O
( O
8 O
% O
) O
English O
HNPCC B-Disease
kindreds O
analysed O
. O

In O
contrast O
, O
the O
MSH2 O
mutation O
was O
identified O
in O
10 O
of O
20 O
( O
50 O
% O
) O
separately O
identified O
colorectal B-Disease
families O
from O
Newfoundland O
. O

To O
investigate O
the O
origin O
of O
this O
mutation O
in O
colorectal B-Disease
cancer I-Disease
families O
from O
England O
( O
n O
= O
4 O
) O
, O
Newfoundland O
( O
n O
= O
10 O
) O
, O
and O
the O
United O
States O
( O
n O
= O
3 O
) O
, O
haplotype O
analysis O
using O
microsatellite O
markers O
linked O
to O
MSH2 O
was O
performed O
. O

Within O
the O
English O
and O
US O
families O
there O
was O
little O
evidence O
for O
a O
recent O
common O
origin O
of O
the O
MSH2 O
splice O
site O
mutation O
in O
most O
families O
. O

In O
contrast O
, O
a O
common O
haplotype O
was O
identified O
at O
the O
two O
flanking O
markers O
( O
CA5 O
and O
D2S288 O
) O
in O
eight O
of O
the O
Newfoundland O
families O
. O

These O
findings O
suggested O
a O
founder O
effect O
within O
Newfoundland O
similar O
to O
that O
reported O
by O
others O
for O
two O
MLH1 O
mutations O
in O
Finnish O
HNPCC B-Disease
families O
. O

We O
calculated O
age O
related O
risks O
of O
all O
, O
colorectal B-Disease
, I-Disease
endometrial I-Disease
, I-Disease
and I-Disease
ovarian I-Disease
cancers I-Disease
in O
nt943 O
+ O
3 O
A O
- O
- O
> O
T O
MSH2 O
mutation O
carriers O
( O
n O
= O
76 O
) O
for O
all O
patients O
and O
for O
men O
and O
women O
separately O
. O

For O
both O
sexes O
combined O
, O
the O
penetrances O
at O
age O
60 O
years O
for O
all O
cancers B-Disease
and O
for O
colorectal B-Disease
cancer I-Disease
were O
0 O
. O

86 O
and O
0 O
. O

57 O
, O
respectively O
. O

The O
risk O
of O
colorectal B-Disease
cancer I-Disease
was O
significantly O
higher O
( O
p O
< O
0 O
. O
01 O
) O
in O
males O
than O
females O
( O
0 O
. O
63 O
v O
0 O
. O
30 O
and O
0 O
. O
84 O
v O
0 O
. O
44 O
at O
ages O
50 O
and O
60 O
years O
, O
respectively O
) O
. O

For O
females O
there O
was O
a O
high O
risk O
of O
endometrial B-Disease
cancer I-Disease
( O
0 O
. O
5 O
at O
age O
60 O
years O
) O
and O
premenopausal B-Disease
ovarian I-Disease
cancer I-Disease
( O
0 O
. O
2 O
at O
50 O
years O
) O
. O

These O
intersex O
differences O
in O
colorectal B-Disease
cancer I-Disease
risks O
have O
implications O
for O
screening O
programmes O
and O
for O
attempts O
to O
identify O
colorectal B-Disease
cancer I-Disease
susceptibility O
modifiers O
. O

Age O
of O
onset O
in O
Huntington B-Disease
disease I-Disease
: O
sex O
specific O
influence O
of O
apolipoprotein O
E O
genotype O
and O
normal O
CAG O
repeat O
length O
. O

Age O
of O
onset O
( O
AO O
) O
of O
Huntington B-Disease
disease I-Disease
( O
HD B-Disease
) O
is O
known O
to O
be O
correlated O
with O
the O
length O
of O
an O
expanded O
CAG O
repeat O
in O
the O
HD B-Disease
gene O
. O

Apolipoprotein O
E O
( O
APOE O
) O
genotype O
, O
in O
turn O
, O
is O
known O
to O
influence O
AO O
in O
Alzheimer B-Disease
disease I-Disease
, O
rendering O
the O
APOE O
gene O
a O
likely O
candidate O
to O
affect O
AO O
in O
other O
neurological B-Disease
diseases I-Disease
too O
. O

We O
therefore O
determined O
APOE O
genotype O
and O
normal O
CAG O
repeat O
length O
in O
the O
HD B-Disease
gene O
for O
138 O
HD B-Disease
patients O
who O
were O
previously O
analysed O
with O
respect O
to O
CAG O
repeat O
length O
. O

